Andrew Nerlinger is the Executive Director of the Global Health Security Fund based in Switzerland, combining his medical background with venture capital expertise. His impressive career spans healthcare, biotechnology, and social impact innovation. After graduating from Yale School of Medicine, he has focused on bridging the gap between medical innovation and investment, particularly through PandemicTech and various venture capital roles. His work in Geneva contributes significantly to global health security and innovation funding in the healthcare sector.